θǻÄÚÊÖÊõ,Intragastric surgeryÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ« Äæ×ªÂ¼³²Ê½¾ÛºÏøÁ´·´Ó¦,reverse transcription-nested polymerase chain reactionÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ« ʳ¹Ü°©êÚÃŰ©,opha-geal and Cardiac CarcinomaÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ« CD44Æ´½Ó±äÒìÌåv6,CD44 splice variant v6Ó¢Óï¶Ì¾ä,Àý¾ä´óÈ« »îÌåÖí¸Î,Live pig liverÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ« ¸¹Ä¤ºó¸±Éñ¾­½ÚÁö,retroperinoneal paragangliomaÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ« ¶ñÐÔ¼äÖÊÁö,Malignant stromal tumorsÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ« Ö×ÁöÏà¹ØÎïÖÊ(TSGF),tumor specific growth factors (TSGF)Ó¢Óï¶Ì¾ä,Àý¾ä´óÈ« θ²Ð°©,Gastic stumpÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ« ¸¹Ç»¶ñÐÔÖ×Áö,malignant abdominal tumorsÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ« ¸ÎÊ®¶þÖ¸³¦ÈÍ´ø¹Ç÷À»¯,Skeletonization of the hepatoduodenal ligamentÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ« Ìǵ÷½Úµ°°×,glucose-regulated proteinÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ« Æ÷еÎǺÏ,anus-preserving operationÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ« 賦¶ñÐÔÖ×Áö,Malignant gastrointestinal tumorÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ« ´óÊó¸Î°©,primary liver cancer of ratÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ« ÁÙ´²ÊÜÒæ,clinical benefitÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ« ÇàÄêÈËθ°©,Gastric cancer in the yongÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ« ÄÚÖ§¼ÜÖÃÈëÊõ,Endovascular stent placementÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ« ×ó¾±²¿ÎǺÏ,Anastomosis through the left neckÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ« ÐØÀªÈë¿Ú,Malignant tumo rÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ« ÓÒÐØÇ°Íâ²àÇпÚ,right anterolateral thoracotomyÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ« ÐÎ̬ѧ±ê×¼,Morphological standardÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ« ½á³¦°©Ï¸°ûϵ,colonic cancer cell linesÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ« ¸¹Ä¤Ö×Áö/Õï¶Ï,Peritoneal neoplasms/diagnosisÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ« ¸¹Ä¤Ö×Áö/ÖÎÁÆ,Peritoneal neoplasms/therapyÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ« WelchÊÖÊõ,Welch operationÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ« ÈËʳ¹Ü°©,human esophageal cancerÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ« θÖ×Áö/¼Ì·¢ÐÔ,STOMACH NEOPLASMS/secondÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ« ¹£×èÐԴ󳦰©,obstructive carcinoma of colonÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ« 125I×ÑÔ´,125 I seedsÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ« Ö÷¶¯ÂöËðÉË,Aortic injuryÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ« ÓªÑøÉÅ,nutritional dietÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ« ¾Ö²¿¸´·¢ÂÊ,Local recurrence rateÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ« Éú³¤×ªÒÆ,Tumor Growth and MetastasisÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ« ¸Îϸ°û»îÁ¦,Activity of hepatocytesÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ« CA24-2,CA24 2Ó¢Óï¶Ì¾ä,Àý¾ä´óÈ« ʳ¹Ü°©/êÚÃŰ©,Oesophageal cancer/cardiac cancerÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ« ´ó³¦ÏÙÁöÐÔÏ¢Èâ,colorectal adenomatous polypÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ« ¸ßƵ͸ÈÈ,high frequency diathermyÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ« Þ²ÂöÆÚ,portal veinous phaseÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ« Dixon,Dixon CLC number:R735.37 Document code:AÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ« ÒÈÏÙÖ×Áö/·ÅÉäÉãÓ°Êõ,pancreatic neoplasms/RAÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ« ð¤ÒºÏ¸°û°©,Mucinous cell carcinomaÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ« ת»¯Éú³¤Òò×Ó¦ÂÐÍÊÜÌå,Transforming growth factor¦Â receptor¢ñÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ« ©ÕïÎóÕï,wrong diagnosis and escapeÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ« 5-Ö¬ÑõºÏøÒÖÖÆ¼Á,lipoxygenase inhibitorsÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ« ¸Î¶¯Âö²å¹Ü»¯ÁÆË¨ÈûÊõ,embolism for hepatic artery catheterization therapyÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ« ÎÚÍ·×¢ÉäÒº,Aconite InjectionÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ« ¾±²¿Ê³¹ÜθÎǺÏÊõ,Cervical esophagogastrostomyÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ« ʳ¹Ü°©Çгý,resection of esophageal cancerÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ« ¶àÔ­·¢´ó³¦°©,Multi-originate colon carcinomaÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ« ʳµÀÈéÍ·×´Áö,esophageal papillomesÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ« ¿Õ³¦Ôì¿Ú¹Ü,Jejunostic tubeÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ« CA199¿¹Ô­,CA 19 9 antigenÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ« Сϸ°û/ÖÎÁÆ,small cell/pa thologyÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ« ѪС°åÒò×Ó,platelet factorÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ« ¹²´æ²¡,incoporate diseaseÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ« RouxÓÙ»ý×ÛºÏÕ÷,Roux stasis syndromeÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ« ÅжÏÔ¤ºó,Prognostic judgementÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ« êÚÃŰ©Êõºó,postoperative cardiac carcinomaÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ« ÍíÆÚθÖ×Áö,Abvanced gastric carcinomaÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ« µÍλǰÇгý,low pre sacrum resection(LPR)Ó¢Óï¶Ì¾ä,Àý¾ä´óÈ« ²¡¶¾ÁÆ·¨,virus therapyÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ« ×ó°ë½á³¦¹£×è,Left colonic obstructionÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ« ¼äÖÊÁö/²¡Àíѧ,Stromal tumor/pathologyÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ« ÊäÄò¹Ü¹£×è/²¡Òòѧ,Ureteral obstruction/etiologyÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ« ¼äÖÊ·´Ó¦,stroma reactionÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ« µç×Ӵ󳦾µ,Video colonoscopeÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ« ¸Î°©¿¹Ô­,HCC antigenÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ« ÒÈÏÙÁ¼ÐÔÖ×Áö,Pancreatic benign tumourÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ« ½þÈóÁܰÍϸ°û,infiltrating lymphocyteÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ« ճĤ°þÀë,endoscopic mucosa resectionÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ« ³¬µÍλǰÇгýÊõ,ultralow anterior resectionÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ« HLA-DP,HLA DPÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ« A3ÏÙÜÕÊÜÌå,A 3 adenosine receptorÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ« ¶¯Âö²å¹Ü»¯ÁÆ,chemotherapy via arterial catheterizationÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ« »·¼ÓÑõøÒÖÖÆ¼Á,Cycol-oxygenase inhibitorÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ« ßÅßáÇèÂÌÅÅйÊÔÑé,indocyanine green excretive testÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ« AFPÒìÖÊÌå,alpha-fetoprotein heterogeneityÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ« µ¼¹ÜÄÚÈéÍ·×´Õ³ÒºÐÔÖ×Áö,Intraductal papillary mucinous tumorsÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ« ½¡Æ¢ÀíÆø·½,Jianpiliqi FormulaÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ« ÎÞÁöÉú´æ,Auto-neoplastic vaclineÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ« ÂÝÐýÌå²ãÉãÓ°Êõ,Spiral TomographyÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ« ÄáÁúȦÌ×Ôú,Nylon Snares` LigationÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ« ¸ßƵµçÄýÇгý,High Frequency ElectrocogulationÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ« p27kip,p27 kipÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ« ¶àÒ©ÄÍҩϸ°û,Multi-drug resistance cellÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ« ¸ÎÑùÏÙ°©,Hepatoid adenocarcinomaÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ« ÄÚ½éÈë·ÅÉäÖÎÁÆ,internal radiotherapyÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ« 賦¼¤ËØÀà/·ÖÎö,GASTROINTESTINAL HORMONES/analysisÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ« θ²¿²¡±ä,stamoch diseaseÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ« ÖÎÁÆÓëÔ¤ºó,Treatment and prognosisÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ« Ö²Èëʽµ¼¹ÜÒ©ºÐϵͳ,Implanted duct-reservoir systemÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ« VEGFÒÖÖÆ¼Á,anti-VEGF agentÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ« ÈýÒ°Çåɨ,three-field lymph node sweepingÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ« ¸Î¶¯Âö²å¹Ü,Hepatic artrictranscatheterÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ« ÒûË®·¨,Method of water drinkingÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ« ·Ö×Ó±êÇ©,genetic tagsÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ« NKϸ°ûɱÉË»îÐÔ,NK cytotoxic indexÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ« ˫ǻθ¾µ,double cavity gastrofiberscopeÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ«